ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 85 filers reported holding ABCELLERA BIOLOGICS INC in Q1 2021. The put-call ratio across all filers is 0.68 and the average weighting 1.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $128,149,000 | 86.19% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $139,409,000 | 7.79% |
| Alpha Wave Global, LP | 2,426,798 | $82,414,000 | 5.13% |
| Orbimed Advisors | 8,200,768 | $278,498,000 | 2.60% |
| VIKING GLOBAL INVESTORS LP | 19,083,744 | $648,084,000 | 1.93% |
| SB Management Ltd | 7,817,190 | $265,472,000 | 1.71% |
| Baker Brothers Advisors | 10,450,180 | $354,888,000 | 1.54% |
| BRANDYWINE MANAGERS, LLC | 19,372 | $658,000 | 0.87% |
| CLOUGH CAPITAL PARTNERS L P | 474,484 | $16,113,000 | 0.72% |
| Duquesne Family Office | 659,750 | $22,405,000 | 0.50% |
| Bullseye Asset Management LLC | 27,299 | $927,000 | 0.35% |
| PURA VIDA INVESTMENTS, LLC | 225,000 | $7,641,000 | 0.22% |
| Moloney Securities Asset Management, LLC | 30,950 | $1,051,000 | 0.21% |
| Woodline Partners LP | 254,902 | $8,656,000 | 0.19% |
| Renaissance Capital LLC | 34,761 | $1,180,000 | 0.18% |
| Paragon Advisors, LLC | 8,840 | $300,000 | 0.16% |
| Alyeska Investment Group, L.P. | 200,000 | $6,792,000 | 0.09% |
| TELEMUS CAPITAL, LLC | 23,700 | $666,000 | 0.05% |
| Lumina Fund Management LLC | 3,000 | $102,000 | 0.04% |
| CREDIT SUISSE AG/ | 2,270,800 | $77,116,000 | 0.04% |
External links
This page lists ABCELLERA BIOLOGICS INC's shareholders in Q1 2021. To view ABCELLERA BIOLOGICS INC's shareholder history, click here.